Sign up for the daily Inside Washington email for exclusive US coverage and analysis sent to your inbox Get our free Inside Washington email Get our free Inside Washington email Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Yet another major pharmaceutical manufacturer has agreed to implement President Donald Trump’s “most favored nation” drug pricing plan and to make its products available on a website for direct-to-consumer sales that will be branded with the president’s name.
AstraZeneca, the U.K.-based drug company, is joining its New York-based rival Pfizer in a White House-led initiative to adopt the president’s preferred pricing model. The company’s CEO, Pascal Soriot, announced the move alongside Trump in the Oval Office on Friday.
“Now drug prices are going to be going down. One hundred percent, 400 percent, 600 percent, 1,000 percent in some cases,” Trump said on Friday.
He said that asthma and COPD inhalers and certain diabetes medicines offered by Astra
Continue Reading on The Independent
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.